Novo Nordisk says completes hemophilia drug trial
COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, said on Friday it had completed the first phase III trial of a hemophilia drug, N9-GP. Full story
Marijuana: the new diet drug?
A new study published in The American Journal of Medicine finds marijuana smokers have better insulin control and smaller waists. MSNBC’s Lawrence O’Donnell discusses the study with Dr. Murray Mittleman of the Harvard School of Public Health, one of the co-authors of the study.
Could Marijuana Reduce Diabetes Risk?
There's an unexpected link between marijuana use and factors related to Type 2 diabetes that has medical researchers intrigued. Full story
Claire McCaskill on getting healthy: I didn't want insulin shots
In Mika Brzezinski's latest book "Obsessed," Sen. Claire McCaskill, D-Mo., tells her story of a life-changing moment where she knew she needed to improve her physical health. Sen. McCaskill joins Morning Joe to discuss her weight-loss journey.
U.S. launch of Novo's new insulin faces long delay
COPENHAGEN (Reuters) - Denmark's Novo Nordisk could see the U.S. launch of its biggest drug hope, a new long-acting insulin, delayed until 2018 while it conducts more tests to satisfy regulators, it said on Wednesday. Full story
Newfound hormone holds hope for diabetes treatment
Scientists have identified a hormone that can sharply boost the number of cells that make insulin in mice, a discovery that may someday lead to a treatment for the most common type of diabetes. Full story
Sponsored Links
Articles
Video
Hispanics may face higher risk for diabetes
A new study says Hispanics are more likely to store fat in their pancreas, but less likely to be able to produce more insulin to compensate for this excess fat, putting them at higher risk for type 2 diabetes. KVEO's Michael Lopez reports.
Saving cash and saving lives
Naomi Wyatt of the Camden Coalition of Health Care Providers joins The Dylan Ratigan Show to talk about hot-spotting in health care.
New treatment for Alzheimer’s ‘promising’
A promising study funded by the National Institutes of Health found that a spritz of insulin may improve memory in Alzheimer’s patients. NBC’s Robert Bazell has more.
Artificial pancreas: Hope for diabetics?
Researchers are working on creating an artificial pancreas that would monitor blood levels and administer insulin. WNYT's Benita Zahn has the report.
Could lo-cal be a cure for Type 2 diabetes?
Doctors say they've had remarkable results in a study to reverse the effects of Type 2 diabetes, with research indicating that a very low-calorie diet could help the body produce its own insulin. ITN’s Katy Fawcett reports.
advertisement | ad info
Related Photos
A diabetic patient displays her insulin supplies and blood sugar level-testing device at the J.W.C.H. safety-net clinic in the center of skid row in downtown Los Angeles
A diabetic patient displays her insulin supplies and blood sugar level-testing device at the J.W.C.H. safety-net clinic in the center of skid row in downtown Los Angeles, July 30, 2007. REUTERS/Lucy Nicholson
Handout shows an employee working on a Novo Nordisk production line for the new long-acting insulin Tresiba drug
An employee works on a Novo Nordisk production line for the new long-acting insulin Tresiba drug, in this August 18, 2012 handout picture provided by Novo Nordisk. U.S. regulators on February 10, 2013 dealt a major blow to Novo Nordisk's hopes for its new long-acting insulin Tresiba by demanding the
Handout shows the new long-acting insulin Tresiba drug on a Novo Nordisk production line
The new long-acting insulin Tresiba drug is seen on a Novo Nordisk production line, in this 2012 handout picture provided by Novo Nordisk. U.S. regulators on February 10, 2013 dealt a major blow to Novo Nordisk's hopes for its new long-acting insulin Tresiba by demanding the Danish drugmaker conduct
